John Overdeck’s VanEck Biotech ETF BBH Stock Holding History

John Overdeck’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.14M	Sell	5,600 -500	-8%	-$94K	﹤0.01%	3512
2026 Q1	$1.15M	Sell	6,100 -5,700	-48%	-$1.1M	﹤0.01%	3163
2025 Q4	$2.23M	Buy	+11,800	New	+$2.18M	﹤0.01%	2356
2025 Q1	–	Sell	-1,900	Closed	-$298K	–	3202
2024 Q4	$298K	Sell	1,900 -700	-27%	-$118K	﹤0.01%	2736
2024 Q3	$461K	Buy	+2,600	New	+$461K	﹤0.01%	2511

Other funds holding BBH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.09B AUM 18.31% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

CCA

Conservest Capital Advisors Wynnewood, Pennsylvania $1.26B AUM 24.75% 1-Year Est. Return

BFG

Bleakley Financial Group Fairfield, New Jersey $7.85B AUM 31.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

John Overdeck's BBH Position: Q2 2026 in Review

John Overdeck reduced its VanEck Biotech ETF (BBH) stake by 8.2% in Q2 2026, selling an estimated $94K and leaving 5,600 shares worth $1.14M. The position accounts for ﹤0.01% of the portfolio, ranked #3512.

John Overdeck first reported a position in BBH in Q3 2024 and has held it in 5 quarters since. The position peaked at $2.23M in Q4 2025. 110 funds tracked by Wall St. Rank hold BBH as of Q2 2026.

John Overdeck held 5,600 shares of VanEck Biotech ETF worth $1.14M as of Q2 2026.
John Overdeck sold 500 VanEck Biotech ETF shares in Q2 2026, an estimated $94K.
VanEck Biotech ETF made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #3512 holding.
John Overdeck first reported a position in VanEck Biotech ETF in Q3 2024 and has held it in 5 quarters since.
John Overdeck's VanEck Biotech ETF position peaked at $2.23M in Q4 2025.
110 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.